Knockdown of PARP16 impacted cardinal features of AD pathology, leading to (i) reduced amyloid deposits, (ii) improved spatial memory dysfunction, and (iii) attenuated neuroinflammation and cell apoptosis. Here, PARP16 is linked to Alzheimer disease.